{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:51:04Z","timestamp":1758477064580},"reference-count":65,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T00:00:00Z","timestamp":1233792000000},"content-version":"vor","delay-in-days":8436,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[1986,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Flecainide acetate is a new class 1 antiar\u2010rhythmic drug. It slows conduction in the working myocardium and the specialized conduction system and may depress sinus node activity in patients with pre\u2010existing sinus node disease. Its hemodynamic effects are minimal. The drug is completely absorbed and shows a half\u2010life of 7\u201322 hours. Elimination is mainly through the kidneys. Flecainide is highly effective in the treatment of ventricular arrhythmias, pre\u2010excitation syndromes and AV reentry tachycardias. Side effects are mild and consist mostly of dizziness, visual disturbances, and nervousness. They rarely require discontinuation of therapy. Proarrhythmic effects have been reported. Caution is required in patients with congestive heart failure, AV block, and\/or bundle\u2010branch block or sinus node dysfunction.<\/jats:p>","DOI":"10.1002\/clc.4960090102","type":"journal-article","created":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T15:33:28Z","timestamp":1233848008000},"page":"1-5","source":"Crossref","is-referenced-by-count":8,"title":["Flecainide: A new antiarrhythmic drug"],"prefix":"10.1002","volume":"9","author":[{"given":"R. A.","family":"Mueller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. R.","family":"Baur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,2,5]]},"reference":[{"key":"e_1_2_1_1_1","first-page":"613","article-title":"Clinical electrophysiological effects of a new anti\u2010arrhythmic agent R818 (flecainide)","volume":"86","author":"Abendroth RR","year":"1980","journal-title":"Proc German Soc Intern Med"},{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(83)90518-5"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198108273050901"},{"issue":"3","key":"e_1_2_1_4_1","first-page":"180","article-title":"Long term therapeutic effect of flecainide in patients with complex tachycardial ventricular rhythm disturbance","volume":"71","author":"Andresen D","year":"1982","journal-title":"Z Kardiol"},{"key":"e_1_2_1_5_1","first-page":"141","volume-title":"Klinische Beobachtungen nach i.v. Injektion von Flecainid","author":"Bender F","year":"1982"},{"issue":"4","key":"e_1_2_1_6_1","first-page":"280","article-title":"Extrasystoliebehandlung mit Flecainid (abstr.). (Treatment of extrasystoles with flecainide)","volume":"68","author":"Bender F","year":"1979","journal-title":"Z Kardiol"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/oxfordjournals.eurheartj.a061432","article-title":"A comparison of the anti\u2010arrhythmic effects of AV junctional re\u2010entrant tachycardia of oral and intravenous flecainide acetate","volume":"4","author":"Bexton RS","year":"1983","journal-title":"Eur Heart J"},{"key":"e_1_2_1_8_1","first-page":"284","article-title":"Effect of flecainide on chronic ventricular arrhythmias","volume":"71","author":"Bluschke V","year":"1982","journal-title":"Z Kardiol"},{"key":"e_1_2_1_9_1","first-page":"11","volume-title":"Pharmakologische und elektrophysiologische Untersuchungen zu Flecainid","author":"Borchard U","year":"1982"},{"key":"e_1_2_1_10_1","first-page":"157","volume-title":"Langzeiter\u2010gebnisse mit dem neuen Antiarrhythmikum Flecainid bei therapiefrakt\u00e4arer, stabiler, chronischer, ventrikul\u00e4arer Extrasystolie unter Beru\u00fcucksichtigung der Plasmaspiegel","author":"Bramann HU","year":"1982"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-66356-7_7"},{"key":"e_1_2_1_12_1","first-page":"278","article-title":"Electrophysiological effects of flecainide on stimulusinducible ventricular tachycardia","volume":"71","author":"Breithardt G","year":"1982","journal-title":"Z Kardiol"},{"key":"e_1_2_1_13_1","first-page":"265","article-title":"Intravenous flecainide\u2013pharmacokinetics and efficacy","volume":"64","author":"Campbell RWF","year":"1981","journal-title":"Circulation"},{"issue":"1","key":"e_1_2_1_14_1","first-page":"2","article-title":"Measurement of flecainide acetate in human plasma by an extraction spectrofluorometric method","volume":"33","author":"Chang SF","year":"1983","journal-title":"Arzh Forsch\/Drug Res"},{"key":"e_1_2_1_15_1","first-page":"342","article-title":"High performance liquid chromatographic method for the quantitation of flecainide, a new antiarrhythmic, in human plasma and urine","volume":"27","author":"Chang SF","year":"1983","journal-title":"J Chromatogr"},{"key":"e_1_2_1_16_1","first-page":"4353","article-title":"A comparative study of Quinidine Retard and flecainide in the treatment of extrasy stoles","volume":"40","author":"Clementy J","year":"1982","journal-title":"Med Hyg"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90501-0"},{"issue":"1","key":"e_1_2_1_18_1","first-page":"2","article-title":"Relationship between plasma concentrations and suppression of ventricular exrasystoles by flecainide acetate (R818), a new anti\u2010arrhythmic in patients","volume":"32","author":"Conard GJ","year":"1982","journal-title":"Arzh Forsch\/Drug Res"},{"issue":"2","key":"e_1_2_1_19_1","article-title":"Binding of flecainide acetate (R818) to human plasma proteins in vitro. American Pharmaceutical Assn., Academy of Pharmaceutical Science. 31st National Meeting, Orlando Nov. 15\u201319, 1981","volume":"2","author":"Conard GJ","journal-title":"Proc. Abstr."},{"key":"e_1_2_1_20_1","first-page":"218","article-title":"Human plasma pharmacokinetics of flecainide acetate (R818), a new antiarrhythmic, following single oral and intravenous doses (abstr.)","volume":"25","author":"Conard GJ","year":"1979","journal-title":"Clin Pharmacal Therap"},{"key":"e_1_2_1_21_1","unstructured":"ConardGJ CarlsonGL FrostJW OberRE LeonAS HunnighakeDB:Human plasma elimination kinetics of R\u2010818 a new antiarrhythmic. In American Pharmaceutical Association Academy of Pharmaceutical Sciences National Meeting 21st Orlando Florida1976.Abstract106"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(81)90234-X"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(81)90331-3"},{"key":"e_1_2_1_24_1","first-page":"143","article-title":"Suppression of complex ventricular arrhythmias by oral flecainide (abstr.)","volume":"66","author":"Duran D","year":"1982","journal-title":"Circulation"},{"issue":"2","key":"e_1_2_1_25_1","first-page":"699","article-title":"Pharmacokinetics and hemodynamic effects of flecainide in patients with chronic low output heart failure","volume":"1","author":"Franciosa JA","year":"1983","journal-title":"Am J Coll Cardiol"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90511-3"},{"key":"e_1_2_1_27_1","first-page":"316","article-title":"Sustained elimination of ventricular arrhythmias during chronic flecainide dosing (abstr.)","volume":"64","author":"Granrud G","year":"1981","journal-title":"Circulation"},{"issue":"2","key":"e_1_2_1_28_1","first-page":"124","article-title":"Anti\u2010arrhythmic therapy with flecainide in acute experimental myocardial infarction","volume":"70","author":"G\u00fculker H","year":"1981","journal-title":"Z Kardiol"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.48.2.140"},{"key":"e_1_2_1_30_1","first-page":"69","article-title":"Effect of flecainide on anomalous pathways and re\u2010entrant junctional tachycardias (abstr.)","volume":"66","author":"Hellestrand KJ","year":"1982","journal-title":"Circulation"},{"issue":"2","key":"e_1_2_1_31_1","first-page":"251","article-title":"Cardiac function after oral dosing with flecainide acetate (abstr.)","volume":"29","author":"Hodges M","year":"1982","journal-title":"Clin Pharmacol Therap Abstra."},{"key":"e_1_2_1_32_1","first-page":"59","volume-title":"Die Wirkung von Flecainid auf h\u00e4amodynamische Parameter in Probanden und in herzkranken Patienten","author":"Hodges M","year":"1982"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.65.5.879"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960060306"},{"key":"e_1_2_1_35_1","first-page":"606","article-title":"Serum protein binding of flecainide","volume":"13","author":"Johnston A","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90506-X"},{"issue":"5","key":"e_1_2_1_37_1","first-page":"340","article-title":"Anti\u2010arrhythmic efficacy of mexiletine, propafenone and flecainide in ventricular premature beats. A comparative study in patients after myocardial infarction","volume":"71","author":"Klempt HW","year":"1982","journal-title":"ZKardiol"},{"issue":"8","key":"e_1_2_1_38_1","first-page":"358","article-title":"Die antiarrhythmische Wirkung von Flecainid bei ventrikul\u00e4arer Extrasystolie (Effects of the new antiarrhythmic agent flecainide on chronic ventricular premature beats)","volume":"12","author":"Klempt HW","year":"1980","journal-title":"Z Kardiol"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(83)80073-3"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(82)90346-5"},{"key":"e_1_2_1_41_1","first-page":"68","article-title":"Comparative efficacy of flecainide vs quinidine for ventricular arrhythmias","volume":"66","author":"Morganroth J","year":"1982","journal-title":"Circulation"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)92468-7"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91238-7"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(84)90368-5"},{"issue":"2","key":"e_1_2_1_45_1","first-page":"557","article-title":"Clinical use of intravenous flecainide for acute atrial, junctional and ventricular tachycardias","volume":"3","author":"Nathan AW","year":"1984","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_1_46_1","first-page":"109","volume-title":"Beeinflussung induzierter supraventrikul\u00e4arer Reentrytachycardien durch Flecainid","author":"Neuss H","year":"1982"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(81)90037-5"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)91364-1"},{"key":"e_1_2_1_49_1","unstructured":"OrningOM:Electrophysiologic effects of flecainide acetate in arrhythmias. InWorld Congress of Cardiology 8th Tokyo September 17\u201323 1978. Abstracts 1 480"},{"key":"e_1_2_1_50_1","first-page":"95","volume-title":"Wirkung von Flecainid auf die elektrophysiologischen Parameter des rechten Ventrikels und His\u2010Purkinje\u2010Systems","author":"Pop T","year":"1982"},{"key":"e_1_2_1_51_1","first-page":"524","article-title":"Electrophysiological effects of the new anti\u2010arrhythmic drug flecainide (R818) in man","volume":"70","author":"Seipel L","year":"1981","journal-title":"Z Kardiol"},{"key":"e_1_2_1_52_1","first-page":"153","article-title":"Electrophysiological effects of flecainide (R818) in man (abstr.)","volume":"62","author":"Seipel L","year":"1980","journal-title":"Circulation"},{"key":"e_1_2_1_53_1","first-page":"175","volume-title":"Flecainid zur Behandlung von postoperativen Arrhythmien","author":"Sigwart U","year":"1982"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.65"},{"key":"e_1_2_1_55_1","first-page":"200","article-title":"Clinical efficacy of a new antiarrhythmic drug. Flecainide","volume":"21","author":"Somani P","year":"1979","journal-title":"Pharmacologist"},{"key":"e_1_2_1_56_1","first-page":"45","article-title":"Flecainide in the treatment of chronic ventricular tachyarrhythmia","volume":"112","author":"Steinbrunn W","year":"1982","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_1_57_1","first-page":"68","article-title":"Effects of flecainide on hemodynamics and functional capacity in heart failure (abstr.)","volume":"66","author":"Tanenbaum R","year":"1982","journal-title":"Circulation"},{"key":"e_1_2_1_58_1","first-page":"1151","article-title":"Anti\u2010arrhythmic efficacy of flecainide in acute myocardial infarction (in dogs) compared to lidocaine","volume":"32","author":"Thale J","year":"1981","journal-title":"Med Welt"},{"issue":"2","key":"e_1_2_1_59_1","first-page":"302","article-title":"Oral digoxin pharmacokinetics during multiple\u2010dose flecainide treatment","volume":"260","author":"Tjandramaga TB","year":"1982","journal-title":"Arch Int Pharmacol Ther"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-039X(75)90019-7"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)90423-4"},{"key":"e_1_2_1_62_1","first-page":"193","volume-title":"Vergleichende Untersuchung der Lang\u2010zeitwirkung von Flecainid und Prajmalinum\u2010Bitartrat bei Patienten mit komplexen ventrikulaeren Rhythmusst\u00f6orungen","author":"von Leitner ER","year":"1982"},{"key":"e_1_2_1_63_1","first-page":"69","article-title":"Suppression of refractory arrhythmias with flecainide (abstr.)","volume":"66","author":"Wang T","year":"1982","journal-title":"Circulation"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.288.6414.344"},{"key":"e_1_2_1_65_1","first-page":"144","article-title":"Effectiveness and tolerance in long\u2010term treatment with flecainide (abstr.)","volume":"66","author":"Zehender M","year":"1982","journal-title":"Circulation"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960090102","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.4960090102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T18:37:44Z","timestamp":1697827064000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960090102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,1]]}},"alternative-id":["10.1002\/clc.4960090102"],"URL":"https:\/\/doi.org\/10.1002\/clc.4960090102","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986,1]]}}}